查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945105

水溶性金奈米棒市場按產品類型、表面功能化、應用、最終用戶和分銷管道分類，全球預測（2026-2032年）

Water-soluble Gold Nanorods Market by Product Type, Surface Functionalization, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，水溶性金奈米棒市場價值將達到 5,137 萬美元，到 2026 年將成長至 5,997 萬美元，到 2032 年將達到 8,184 萬美元，複合年成長率為 6.87%。

關鍵市場統計數據
基準年 2025 5137萬美元
預計年份：2026年 5997萬美元
預測年份 2032 8184萬美元
複合年成長率 (%) 6.87%

本書權威地介紹了水溶性金奈米棒的科學原理、穩定性以及決定其在生物醫學和工業應用中實用化因素。

水溶性金奈米棒融合了奈米技術、表面化學和生物醫學工程，在成像、治療、感測和催化等眾多領域展現出日益重要的應用價值。這些異向性奈米顆粒不僅具有金的固有等離子體特性，其可調的長寬比和表面化學性質使其能夠在水性生物和化學環境中實現可控的相互作用。其溶解性和膠體穩定性對於轉化研究至關重要，因為它們與水溶液的相容性為與生理介質、製劑製程以及下游分析技術的兼容性奠定了基礎。

合成擴充性、表面改質技術和合作商業化的進步如何改變水溶性金奈米棒的未來

隨著合成擴充性、表面設計和監管的同步發展，水溶性金奈米棒的研究模式也不斷演變。過去，研究重點主要集中在概念驗證的光學性質和體外性能上，而現在，研究方向已明顯轉向穩健、可擴展的化學方法，以實現一致的長寬比和最小的批次間差異。這種轉變的驅動力源於從探索性研究轉向可重複性材料的需求，以支持臨床前和早期臨床計畫。

評估2025年美國關稅如何影響奈米材料研發領域的供應鏈韌性、採購和業務永續營運

美國2025年關稅的實施和調整為從事水溶性金奈米棒研究的機構帶來了新的供應鏈和採購的考量。依賴進口前驅物、特種界面活性劑或契約製造服務的公司被迫重新評估其短期籌資策略和物流，以維持研發和生產的連續性。這些變化促使許多相關人員重新考慮供應商多元化、庫存管理和本地採購方案，以確保實驗進度和生產計畫的順利進行。

基於詳細細分市場的洞察揭示了應用領域、終端用戶需求、產品形式、通路和表面化學性質如何決定研發和商業化重點。

細分領域揭示了技術和商業性優先事項的交匯點，以及研發資源能發揮最大作用的領域。應用主導的細分則揭示了生物成像、催化作用、藥物傳遞、動態療法、光熱治療和感測等領域的廣泛研究活動。在生物成像領域，研究分為電腦斷層掃描和磁振造影，其中造影機制和功能塗層會影響生物分佈和檢測靈敏度。藥物遞送應用分為化療和基因遞送途徑，每種途徑對有效載荷相容性、釋放動力學和安全性評估的要求各不相同。光熱治療研究進一步分為體外和體內兩種環境，其中熱劑量控制和標靶化策略對於潛在的臨床應用日益重要。感測研發分為電化學感測和光學感測，反映了不同的讀出方法、表面化學性質和整合挑戰。

影響採購、監管和臨床路徑的區域趨勢和策略生態系統（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢為水溶性金奈米棒的開發和應用帶來了不同的機會和挑戰。在美洲，以臨床應用為導向的生物醫學研究實力雄厚，成熟的創業環境以及密集的臨床研究中心網路，正推動著早期合作和臨床試驗的發展。該地區的生態系統支持學術研究機構與產業參與者之間的合作，重點關注臨床效用研究和中試生產能力。歐洲、中東和非洲地區擁有多元化的環境，健全的法規結構、一體化的研究叢集以及對安全和環境管治的重視，促進了嚴謹的臨床前評估和監管對話；同時，部分國家的新興研究中心推動了本地化生產和專業化應用。亞太地區兼具大規模生產能力和對奈米醫學及診斷平台快速成長的投資，有利於規模化生產和成本效益，並促進製造商與下游醫療設備和製藥整合商之間的密切合作。

技術提供者之間的競爭行為和策略能力著重於規模化、表面功能化和完善的品質體系，以加速轉化夥伴關係。

在水溶性金奈米棒領域，各公司透過可擴展的合成方法、先進的表面功能化技術和監管合規能力來脫穎而出。市場參與企業涵蓋了專業的奈米材料製造商、學術創業公司以及提供配方開發、規模化生產和分析服務的合約研發生產機構 (CDMO)。許多機構致力於開發整合解決方案，將顆粒合成、偶聯技術和嚴謹的表徵流程相結合，以加速從實驗室演示到實用化應用結構的轉換。

為加強可重複性、監管應對力和策略夥伴關係，以加速轉化研究進展，各組織應採取實際的優先行動

為了將技術可能性轉化為可驗證且可重複的成果，並滿足研究、臨床和商業相關人員的需求，行業領導者應重點推進以下舉措：首先，透過投資穩健且可擴展的合成和品管框架，降低下游開發風險，最大限度地減少長寬比變異性，並確保在生理條件下膠體穩定性。其次，優先考慮多功能表面策略，根據需要將隱形塗層與標靶分子和可裂解連接子結合，以提高特異性，同時保持良好的安全性。第三，制定供應商資質認證計劃和區域採購計劃，以降低貿易政策變更和供應中斷帶來的風險，並確保關鍵投入的持續供應。

本研究的基礎研究採用以證據為基礎的混合方法研究途徑，結契約儕審查的技術文獻、專利映射、專家訪談和供應鏈分析，以確保得出可靠的研究結果。

本分析所依據的研究採用混合方法，結合實驗文獻、專利概況、專家訪談和供應鏈圖譜，全面展現此技術及其生態系。技術見解由同行評審的合成通訊協定、光學表徵和功能化化學研究以及針對膠體穩定性和生物相容性的方法比較研究提供支持。專利分析識別出創新集中的領域，從而深入了解智慧財產權趨勢和潛在的自由實施權。

合成技術、表面改質技術和合作實用化策略將共同決定水溶性金奈米棒的潛力能否轉化為永續的現實世界應用。

水溶性金奈米棒兼具科學潛力與實用化挑戰。其獨特的光學性質和表面可調控性使其在成像、感測、標靶治療等眾多領域極具吸引力。然而，要實現更廣泛的應用，關鍵在於可重複的合成方法、明確的表面化學性質以及嚴格的安全性評估。能夠將自身能力（例如嚴謹的分析能力、法規專業知識和生產夥伴關係關係）與目標應用策略結合的相關人員，將更有利於推動原型產品邁向實用化目標。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 水溶性金奈米棒市場（依產品類型分類）

  • 長棒狀分子（超過50奈米）
  • 短棒狀分子（小於50奈米）

9. 水溶性金奈米棒市場（依表面功能化分類）

  • 抗體包被
  • 聚乙二醇化
  • 胜肽塗層

第10章 水溶性金奈米棒市場依應用領域分類

  • 生物影像
    • CT影像
    • 磁振造影
  • 催化作用
  • 藥物輸送
    • 化療藥物輸送
    • 基因傳遞
  • 動態療法
  • 光熱治療
  • 感測
    • 電化學感測
    • 光學感

第11章 水溶性金奈米棒市場（依最終用戶分類）

  • 學術機構
  • 診斷中心
  • 製藥公司
  • 研究所

第12章 水溶性金奈米棒市場（依通路分類）

  • 直銷
  • 經銷商
  • 線上管道

第13章 水溶性金奈米棒市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 水溶性金奈米棒市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國水溶性金奈米棒市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國水溶性金奈米棒市場

第17章：中國水溶性金奈米棒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Bangs Laboratories, Inc.
  • BBI Solutions OEM Limited
  • CD Bioparticles
  • Creative Biolabs
  • Cytodiagnostics Inc.
  • Meliorum Technologies Inc.
  • Nano Labs
  • NanoComposix Inc.
  • Nanocs Inc.
  • NanoHybrids Inc.
  • Nanopartz Inc.
  • Nanoprobes, Inc.
  • Nanotherapeutics, Inc.
  • PlasmaChem GmbH
  • Sigma-Aldrich Corporation by Merck Group
  • Sona Nanotech
  • Strem Chemicals, Inc. by Ascensus Specialties LLC
  • TANAKA Holdings Co., Ltd.
Product Code: MRR-8D2A80511E82

The Water-soluble Gold Nanorods Market was valued at USD 51.37 million in 2025 and is projected to grow to USD 59.97 million in 2026, with a CAGR of 6.87%, reaching USD 81.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 51.37 million
Estimated Year [2026] USD 59.97 million
Forecast Year [2032] USD 81.84 million
CAGR (%) 6.87%

An authoritative primer on the science, stability, and translational enablers that define water-soluble gold nanorods for biomedical and industrial applications

Water-soluble gold nanorods represent a convergence of nanotechnology, surface chemistry, and biomedical engineering with growing relevance across imaging, therapy, sensing, and catalysis. These anisotropic nanoparticles combine the plasmonic properties inherent to gold with tunable aspect ratios and surface chemistries that enable controlled interactions in aqueous biological and chemical environments. Their solubility and colloidal stability are central to translational research, because aqueous compatibility underpins compatibility with physiological media, formulation workflows, and downstream analytical techniques.

As interest in precision medicine and advanced diagnostics intensifies, researchers and technology adopters are refining synthesis protocols to yield reproducible particle geometries and narrow dispersity. Concurrently, surface functionalization strategies-ranging from polyethylene glycol grafting to antibody and peptide conjugation-extend biological targeting, minimize non-specific adsorption, and modulate circulation times. In parallel, advances in characterization such as single-particle spectroscopy, cryo-electron microscopy, and high-resolution chromatographic separation are improving quality control and batch comparability.

Regulatory awareness and safety profiling remain essential for adoption beyond academic labs. Toxicology assays increasingly emphasize long-term clearance pathways, protein corona effects, and dose-dependent biodistribution. Taken together, these technical and translational considerations establish water-soluble gold nanorods as a versatile platform that bridges laboratory innovation with heightened expectations for manufacturability, reproducibility, and clinical relevance.

How converging advances in synthesis scalability, surface engineering, and collaborative commercialization are reshaping the trajectory of water-soluble gold nanorods

The landscape for water-soluble gold nanorods is shifting as synthesis scalability, surface engineering, and regulatory scrutiny evolve in tandem. Historically, emphasis rested on demonstrating proof-of-concept optical properties and in vitro performance, but there is now a clear shift toward robust, scalable chemistries that deliver consistent aspect ratios and minimized batch-to-batch variability. This evolution is driven by the need to move from exploratory studies to reproducible materials that can underpin preclinical and early clinical programs.

Simultaneously, surface functionalization has matured from simple stabilizing ligands to multifunctional coatings designed to achieve targeted delivery, stealth behavior, and triggered responses. For example, PEGylation remains a standard approach to reduce opsonization, while antibody and peptide coatings introduce specificity for cellular and molecular targets. As a result, the technology is transitioning from purely optical demonstrators to integrated therapeutic and diagnostic constructs that can be engineered for multimodal applications.

Finally, the commercialization pathway is increasingly influenced by cross-sector collaborations between academic spinouts, contract development organizations, and device and pharmaceutical developers. These partnerships accelerate validation in application contexts such as imaging, sensing, and photothermal interventions, while also creating clearer expectations for manufacturing controls, documentation, and regulatory alignment. The cumulative effect is a more disciplined ecosystem that prioritizes reproducibility, translational readiness, and strategic alliances to bridge laboratory advances with real-world use cases.

Assessing how recent U.S. tariff measures enacted in twenty twenty-five are reshaping supply chain resilience, sourcing, and operational continuity in nanomaterials development

The imposition and adjustment of tariffs by the United States in twenty twenty-five have introduced a new dimension of supply chain and sourcing considerations for organizations working with water-soluble gold nanorods. Companies that rely on imported precursors, specialized surfactants, or contract manufacturing services have had to evaluate near-term procurement strategies and logistics to preserve continuity of research and production. These shifts have prompted many stakeholders to re-examine supplier diversification, inventory management, and regional sourcing alternatives in order to maintain experimental timelines and production schedules.

In response, some research organizations and manufacturers prioritized local supplier qualification and expanded relationships with regional chemical producers to reduce exposure to cross-border tariff fluctuations. At the same time, laboratories and product developers adjusted procurement planning to account for longer lead times and potential cost variability for certain reagents and specialty substrates. The ripple effects also touched collaborative projects that involve international partners, necessitating clearer contractual terms around responsibilities for customs, duties, and materials transfer.

Looking forward, these trade policy dynamics reinforced the value of transparency in supplier capabilities and traceability in material provenance. Organizations that invest in validated domestic supply chains and robust quality assurance pathways can mitigate risk and strengthen operational resilience. Equally, entities that map their exposure to tariff-sensitive inputs and maintain adaptive sourcing strategies are better positioned to sustain development momentum amid trade policy volatility.

Detailed segmentation-driven insights revealing how application niches, end-user needs, product geometry, distribution pathways, and surface chemistries define R&D and commercialization priorities

Segment-level differentiation illuminates where technical and commercial priorities intersect and where development resources offer the greatest leverage for impact. Application-driven segmentation shows a broad distribution of activity across biological imaging, catalysis, drug delivery, photodynamic therapy, photothermal therapy, and sensing. Within biological imaging, research divides into computed tomography and magnetic resonance approaches where contrast mechanisms and functional coatings alter biodistribution and detection sensitivity. Drug delivery applications separate into chemotherapeutic delivery and gene delivery pathways, each demanding distinct payload compatibility, release kinetics, and safety assessments. Photothermal therapy work is further distinguished by in vitro versus in vivo contexts, with thermal dose control and targeting strategies becoming critical for translational candidacy. Sensing R&D bifurcates into electrochemical and optical sensing, reflecting differing readout modalities, surface chemistries, and integration challenges.

End-user segmentation underscores how adoption pathways vary across research and commercial settings. Academic institutes and research institutes typically drive fundamental innovation, method development, and early validation, whereas diagnostic centers and pharmaceutical companies focus on clinical utility, regulatory alignment, and integration into workflows. Product type segmentation highlights distinctions between long rods with greater than fifty nanometer dimensions and short rods below that threshold, which exhibit different optical resonances, cellular interactions, and clearance behaviors. Distribution channel segmentation shapes purchasing and support expectations through direct sales, distributors, and online channels, each with tradeoffs in technical support, batch traceability, and turnaround times. Surface functionalization segmentation - including antibody-coated, PEGylated, and peptide-coated variants - directs intended biological interactions, immunogenicity profiles, and targeting specificity, thereby influencing translational strategies at every stage.

Regional dynamics and strategic ecosystems across the Americas, Europe Middle East & Africa, and Asia Pacific that influence sourcing, regulation, and translational pathways

Regional dynamics create distinct opportunity sets and constraints for the development and adoption of water-soluble gold nanorods. In the Americas, strength in translational biomedical research, a mature venture landscape, and a dense network of clinical research sites drive early-stage collaborations and translational testing. This regional ecosystem supports partnerships between academic labs and industry players focused on clinical utility studies and pilot manufacturing capabilities. Europe, Middle East & Africa present a heterogeneous landscape where strong regulatory frameworks, consolidated research clusters, and an emphasis on safety and environmental governance encourage rigorous preclinical evaluation and dialogue with regulatory agencies; meanwhile, emerging research centers in certain countries are advancing localized manufacturing and specialized applications. Asia-Pacific combines high-volume manufacturing capabilities with rapidly growing investment in nanomedicine and diagnostic platforms, encouraging scale-up and cost-efficient production as well as close integration between manufacturers and downstream device or pharmaceutical integrators.

Supply chain composition and regulatory environments also differ across these regions, shaping decisions about where to qualify suppliers, establish contract development and manufacturing partnerships, and conduct pivotal preclinical work. For example, proximity to specialty chemical suppliers and instrument manufacturers can shorten development cycles in certain Asia-Pacific hubs, while established clinical trial networks in the Americas and parts of Europe support more rapid translational assessments. These regional distinctions inform strategic choices about pilot production, regulatory engagement, and partnership models that best align with organizational priorities and timelines.

Competitive behaviors and strategic capabilities among technology providers that emphasize scale-up, surface functionalization, and documented quality systems to accelerate translational partnerships

Companies operating in the water-soluble gold nanorod space are differentiating through capabilities in scalable synthesis, advanced surface functionalization, and regulatory alignment. Market participants range from specialized nanomaterials manufacturers and academic spinouts to contract development and manufacturing organizations that provide formulation, scale-up, and analytical services. Many organizations emphasize integrated solutions that combine particle synthesis with conjugation expertise and rigorous characterization workflows to shorten the path from laboratory proof to application-ready constructs.

Strategic behavior includes forming multidisciplinary alliances that bring together chemists, biologists, and engineers to address complex translational challenges such as in vivo stability, immunogenicity, and delivery efficiency. In addition, some providers are investing in standardized quality systems and documented production processes to improve reproducibility and to facilitate regulatory conversations. Contract research and manufacturing relationships are growing more common as end users seek partners that can support method transfer, scale-up, and lot release testing.

At the same time, intellectual property considerations influence collaboration structures. Patent landscapes around synthesis techniques, surface chemistries, and application-specific conjugates encourage licensing discussions and guarded technology transfer approaches. Companies with strong analytical platforms and validated safety data are better positioned to attract partnerships with diagnostic developers and therapeutic integrators, and firms that can demonstrate consistent manufacturing and documentation practices secure an advantage when negotiating development contracts and supply agreements.

Practical and prioritized actions for organizations to enhance reproducibility, regulatory readiness, and strategic partnerships that accelerate translational progress

Industry leaders should pursue a set of targeted actions to convert technical promise into demonstrable, reproducible outcomes that satisfy research, clinical, and commercial stakeholders. First, invest in robust, scalable synthesis and quality-control frameworks that minimize aspect ratio variability and ensure colloidal stability under physiological conditions, thereby reducing downstream development risk. Second, prioritize multifunctional surface strategies, combining stealth coatings with targeting moieties and cleavable linkers where appropriate, to enhance specificity while maintaining favorable safety profiles. Third, develop supplier qualification programs and regional sourcing plans to mitigate exposure to trade policy shifts and supply disruptions, ensuring continuity of critical inputs.

Fourth, integrate preclinical safety and pharmacokinetic studies early to validate clearance mechanisms, protein corona dynamics, and dose-dependent biodistribution, and align experimental design with regulatory expectations to expedite review conversations. Fifth, establish partnerships with contract development and manufacturing organizations that can demonstrate analytical rigor and method transfer experience, enabling smoother transitions from bench to pilot production. Sixth, create interdisciplinary teams that include regulatory, clinical, and commercial expertise to craft go-to-market strategies tailored to imaging, therapeutic, and sensing applications. By implementing these actions in parallel, organizations can reduce translational friction and better position their technologies for adoption across both research and clinical markets.

An evidence-based mixed-methods research approach combining peer-reviewed technical literature, patent mapping, expert interviews, and supply chain analysis to ensure robust insights

The research underpinning this analysis draws on a mixed-methods approach that triangulates experimental literature, patent landscapes, expert interviews, and supply chain mapping to provide a holistic view of the technology and its ecosystem. Technical insights were informed by peer-reviewed studies on synthesis protocols, optical characterization, and functionalization chemistries, as well as by method comparison studies that address colloidal stability and biocompatibility. Patent analysis identified areas of concentrated innovation, informing discussion on intellectual property dynamics and potential freedom-to-operate considerations.

Qualitative inputs came from structured interviews with academic investigators, R&D leaders in companies developing nanomaterials, and specialists in regulatory science and manufacturing scale-up. These conversations illuminated practical barriers to translation, such as analytical gaps, documentation needs, and partnership expectations. Finally, supply chain mapping and procurement interviews provided visibility into typical sourcing pathways, logistical constraints, and regional manufacturing capabilities. Throughout, careful attention was paid to corroborating claims across multiple sources and to contextualizing findings within current regulatory trends and best-practice approaches to nanomaterial characterization and safety assessment.

Synthesis, surface engineering, and collaborative translational strategies that collectively determine whether the promise of water-soluble gold nanorods converts into sustained real-world applications

Water-soluble gold nanorods sit at an intersection of scientific opportunity and pragmatic development challenges. Their unique optical and surface-tunable properties make them attractive for a range of applications from imaging and sensing to targeted therapy, yet the pathway to broader adoption requires attention to reproducible synthesis, well-defined surface chemistries, and rigorous safety characterization. Stakeholders who align internal capabilities-such as analytical rigor, regulatory expertise, and manufacturing partnerships-with targeted application strategies will be best positioned to advance prototypes toward translational milestones.

Moreover, the evolving trade and supply chain landscape underscores the importance of flexible sourcing strategies and regional qualification to preserve momentum in research and production. Collaboration across disciplines and sectors remains a powerful lever to resolve technical bottlenecks and to accelerate validation in clinically relevant contexts. In summary, the technology's promise is real, but realizing that promise at scale depends on disciplined engineering, strategic partnerships, and a proactive approach to regulatory and supply chain risks.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Water-soluble Gold Nanorods Market, by Product Type

  • 8.1. Long Rods (>50 Nm)
  • 8.2. Short Rods (<50 Nm)

9. Water-soluble Gold Nanorods Market, by Surface Functionalization

  • 9.1. Antibody Coated
  • 9.2. PEGylated
  • 9.3. Peptide Coated

10. Water-soluble Gold Nanorods Market, by Application

  • 10.1. Biological Imaging
    • 10.1.1. CT Imaging
    • 10.1.2. MRI Imaging
  • 10.2. Catalysis
  • 10.3. Drug Delivery
    • 10.3.1. Chemotherapeutic Delivery
    • 10.3.2. Gene Delivery
  • 10.4. Photodynamic Therapy
  • 10.5. Photothermal Therapy
  • 10.6. Sensing
    • 10.6.1. Electrochemical Sensing
    • 10.6.2. Optical Sensing

11. Water-soluble Gold Nanorods Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Water-soluble Gold Nanorods Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Channels

13. Water-soluble Gold Nanorods Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Water-soluble Gold Nanorods Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Water-soluble Gold Nanorods Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Water-soluble Gold Nanorods Market

17. China Water-soluble Gold Nanorods Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Bangs Laboratories, Inc.
  • 18.7. BBI Solutions OEM Limited
  • 18.8. CD Bioparticles
  • 18.9. Creative Biolabs
  • 18.10. Cytodiagnostics Inc.
  • 18.11. Meliorum Technologies Inc.
  • 18.12. Nano Labs
  • 18.13. NanoComposix Inc.
  • 18.14. Nanocs Inc.
  • 18.15. NanoHybrids Inc.
  • 18.16. Nanopartz Inc.
  • 18.17. Nanoprobes, Inc.
  • 18.18. Nanotherapeutics, Inc.
  • 18.19. PlasmaChem GmbH
  • 18.20. Sigma-Aldrich Corporation by Merck Group
  • 18.21. Sona Nanotech
  • 18.22. Strem Chemicals, Inc. by Ascensus Specialties LLC
  • 18.23. TANAKA Holdings Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 168. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 172. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 195. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 199. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 204. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 208. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)